Clinical Trial Update: Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women [Phase 4]

View source ↗

Summary

Phase 4, non-comparative clinical trial sponsored by Pfizer evaluated changes in flow-mediated dilation after quinapril therapy in hypertensive women. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Accupril (Quinapril)

Snippet

Sponsor: Pfizer | Conditions: Menopause, Hypertension | Phase 4 | Status: COMPLETED